Cargando…
Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19
Coronavirus disease 2019 (COVID-19) infection causes acute lung injury, resulting from aggressive inflammation initiated by viral replication. There has been much speculation about the potential role of non-steroidal inflammatory drugs (NSAIDs), which increase the expression of angiotensin-convertin...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465199/ https://www.ncbi.nlm.nih.gov/pubmed/32785086 http://dx.doi.org/10.3390/jcm9082586 |
_version_ | 1783577535294996480 |
---|---|
author | Bruce, Eilidh Barlow-Pay, Fenella Short, Roxanna Vilches-Moraga, Arturo Price, Angeline McGovern, Aine Braude, Philip Stechman, Michael J. Moug, Susan McCarthy, Kathryn Hewitt, Jonathan Carter, Ben Myint, Phyo Kyaw |
author_facet | Bruce, Eilidh Barlow-Pay, Fenella Short, Roxanna Vilches-Moraga, Arturo Price, Angeline McGovern, Aine Braude, Philip Stechman, Michael J. Moug, Susan McCarthy, Kathryn Hewitt, Jonathan Carter, Ben Myint, Phyo Kyaw |
author_sort | Bruce, Eilidh |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) infection causes acute lung injury, resulting from aggressive inflammation initiated by viral replication. There has been much speculation about the potential role of non-steroidal inflammatory drugs (NSAIDs), which increase the expression of angiotensin-converting enzyme 2 (ACE2), a binding target for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter the host cell, which could lead to poorer outcomes in COVID-19 disease. The aim of this study was to examine the association between routine use of NSAIDs and outcomes in hospitalised patients with COVID-19. This was a multicentre, observational study, with data collected from adult patients with COVID-19 admitted to eight UK hospitals. Of 1222 patients eligible to be included, 54 (4.4%) were routinely prescribed NSAIDs prior to admission. Univariate results suggested a modest protective effect from the use of NSAIDs, but in the multivariable analysis, there was no association between prior NSAID use and time to mortality (adjusted HR (aHR) = 0.89, 95% CI 0.52–1.53, p = 0.67) or length of stay (aHR 0.89, 95% CI 0.59–1.35, p = 0.58). This study found no evidence that routine NSAID use was associated with higher COVID-19 mortality in hospitalised patients; therefore, patients should be advised to continue taking these medications until further evidence emerges. Our findings suggest that NSAID use might confer a modest benefit with regard to survival. However, as this finding was underpowered, further research is required. |
format | Online Article Text |
id | pubmed-7465199 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74651992020-09-04 Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19 Bruce, Eilidh Barlow-Pay, Fenella Short, Roxanna Vilches-Moraga, Arturo Price, Angeline McGovern, Aine Braude, Philip Stechman, Michael J. Moug, Susan McCarthy, Kathryn Hewitt, Jonathan Carter, Ben Myint, Phyo Kyaw J Clin Med Article Coronavirus disease 2019 (COVID-19) infection causes acute lung injury, resulting from aggressive inflammation initiated by viral replication. There has been much speculation about the potential role of non-steroidal inflammatory drugs (NSAIDs), which increase the expression of angiotensin-converting enzyme 2 (ACE2), a binding target for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter the host cell, which could lead to poorer outcomes in COVID-19 disease. The aim of this study was to examine the association between routine use of NSAIDs and outcomes in hospitalised patients with COVID-19. This was a multicentre, observational study, with data collected from adult patients with COVID-19 admitted to eight UK hospitals. Of 1222 patients eligible to be included, 54 (4.4%) were routinely prescribed NSAIDs prior to admission. Univariate results suggested a modest protective effect from the use of NSAIDs, but in the multivariable analysis, there was no association between prior NSAID use and time to mortality (adjusted HR (aHR) = 0.89, 95% CI 0.52–1.53, p = 0.67) or length of stay (aHR 0.89, 95% CI 0.59–1.35, p = 0.58). This study found no evidence that routine NSAID use was associated with higher COVID-19 mortality in hospitalised patients; therefore, patients should be advised to continue taking these medications until further evidence emerges. Our findings suggest that NSAID use might confer a modest benefit with regard to survival. However, as this finding was underpowered, further research is required. MDPI 2020-08-10 /pmc/articles/PMC7465199/ /pubmed/32785086 http://dx.doi.org/10.3390/jcm9082586 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bruce, Eilidh Barlow-Pay, Fenella Short, Roxanna Vilches-Moraga, Arturo Price, Angeline McGovern, Aine Braude, Philip Stechman, Michael J. Moug, Susan McCarthy, Kathryn Hewitt, Jonathan Carter, Ben Myint, Phyo Kyaw Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19 |
title | Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19 |
title_full | Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19 |
title_fullStr | Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19 |
title_full_unstemmed | Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19 |
title_short | Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19 |
title_sort | prior routine use of non-steroidal anti-inflammatory drugs (nsaids) and important outcomes in hospitalised patients with covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465199/ https://www.ncbi.nlm.nih.gov/pubmed/32785086 http://dx.doi.org/10.3390/jcm9082586 |
work_keys_str_mv | AT bruceeilidh priorroutineuseofnonsteroidalantiinflammatorydrugsnsaidsandimportantoutcomesinhospitalisedpatientswithcovid19 AT barlowpayfenella priorroutineuseofnonsteroidalantiinflammatorydrugsnsaidsandimportantoutcomesinhospitalisedpatientswithcovid19 AT shortroxanna priorroutineuseofnonsteroidalantiinflammatorydrugsnsaidsandimportantoutcomesinhospitalisedpatientswithcovid19 AT vilchesmoragaarturo priorroutineuseofnonsteroidalantiinflammatorydrugsnsaidsandimportantoutcomesinhospitalisedpatientswithcovid19 AT priceangeline priorroutineuseofnonsteroidalantiinflammatorydrugsnsaidsandimportantoutcomesinhospitalisedpatientswithcovid19 AT mcgovernaine priorroutineuseofnonsteroidalantiinflammatorydrugsnsaidsandimportantoutcomesinhospitalisedpatientswithcovid19 AT braudephilip priorroutineuseofnonsteroidalantiinflammatorydrugsnsaidsandimportantoutcomesinhospitalisedpatientswithcovid19 AT stechmanmichaelj priorroutineuseofnonsteroidalantiinflammatorydrugsnsaidsandimportantoutcomesinhospitalisedpatientswithcovid19 AT mougsusan priorroutineuseofnonsteroidalantiinflammatorydrugsnsaidsandimportantoutcomesinhospitalisedpatientswithcovid19 AT mccarthykathryn priorroutineuseofnonsteroidalantiinflammatorydrugsnsaidsandimportantoutcomesinhospitalisedpatientswithcovid19 AT hewittjonathan priorroutineuseofnonsteroidalantiinflammatorydrugsnsaidsandimportantoutcomesinhospitalisedpatientswithcovid19 AT carterben priorroutineuseofnonsteroidalantiinflammatorydrugsnsaidsandimportantoutcomesinhospitalisedpatientswithcovid19 AT myintphyokyaw priorroutineuseofnonsteroidalantiinflammatorydrugsnsaidsandimportantoutcomesinhospitalisedpatientswithcovid19 |